Georgia Society of Health-SystemPharmacistsOur mission is to help our members become better practitioners. |
GSHP 2025 Spring Meeting.
March 21-23, 2025
Marriott Riverfront
Savannah, GA
GSHP Spring Meeting Agenda as of 1/14/2025 |
|||
Program Key |
|||
General Session |
|||
|
|||
|
|||
Special Events |
|||
|
|
|
|
Date and Time |
Credit Hrs. |
Topic |
Speaker |
Thursday, March 20, 2025 |
|
|
|
3:00pm-5:00pm |
|
GSHP Board of Directors Meeting |
|
6:00pm-8:00pm |
Director of Pharmacy Dinner hosted by GSHP Board of Directors |
||
Friday, March 21, 2025 |
|
|
|
7:00am-7:45am |
|
Registration and Breakfast |
|
8:00-9:00am |
1 |
Pharmacy Advocacy in Motion: Updates from the ASHP House of Delegates Objectives: 1. Review recent actions considered by the ASHP House of Delegates 2. Conduct a mock House of Delegates session 3. Analyze proposed action from the House of Delegates |
Davey Legendre, PharmD, MBA, BCPS, BCIDP, FASHP Vice-President, Pharmacy Management PharmD on Demand |
9:00-10:00am |
1 |
The Pharmacist’s Role in Palliative Care Objectives: 1. Define palliative care 2. Understand the importance of defining goals of care throughout the disease process 3. Recommend symptom management medication frequently used at end of life 4. Identify common misconceptions related to medication usage at end of life
|
Katie Maples, PharmD Pain & Palliative Care Coordinator Opioid Stewardship Pharmacist UF Health Jacksonville |
10:00-11:00 am |
1 |
Insights and Solutions for Rural Hospital Pharmacy Issue Objectives: 1. Provide strategies and critical thinking tools to manage expensive but often life-saving medications 2. Highlight options and management approach for 340b programs as well as inventory oversight and control 3. Describe how to engage networking to solve the one pharmacist health system hurdles 4. Detail options and creative ways to provide patient care within the new USP 797 updates and remain fiscally responsible |
Kameron Huffman, PharmD, MBA Regional Pharmacy Manager PharmD on Demand Emily Taylor, PharmD Clinical Pharmacy Manager John D. Archbold Memorial Hospital - Mitchell |
11:00am-1:00 pm |
|
Lunch and Exhibits |
|
1:00-2:00 pm |
1 |
Advances in Hemophilia Management Objectives: 1. Explain the underlying causes and types of hemophilia (e.g., Hemophilia A and B). 2. Describe therapies for hemophilia, including factor replacement therapy, non-factor replacement options, and gene therapy. 3. Examine the challenges in implementing gene therapy for hemophilia |
Katherine Saunders, PharmD, BCOP Oncology Pharmacy Supervisor Wellstar MCG Health |
2:00-3:00 pm |
1 |
Not a Long Shot: The Next Wave of HIV Treatment Objectives: 1. Describe antiretroviral treatment options for HIV 2. Examine the place in HIV therapy for current long-acting antiretroviral treatment options 3. Apply current long-acting antiretroviral treatment options to a patient case |
Bradley L. Smith, PharmD, BCACP, AAHIVP Clinical Pharmacist Specialist Grady Health System |
3:00-3:15pm |
|
Break |
|
3:15pm- 4:15pm |
1 |
Linked in to Success: Building Your Pharmacy Network Objectives: 1. Develop strategic networking techniques to build meaningful professional relationships 2. Demonstrate professional etiquette and boundaries when engaging others in various pharmacy settings 3. Develop mentorship skills to both seek and provide guidance within pharmacy practice 4. Apply active listening and digital networking tools to strengthen professional connections |
Nicholas Barker, PharmD, BCCP, BCCCP Clinical Pharmacy Manager Emory Saint Joseph’s Hospital |
4:20- 6:15pm |
|
RECEPTION/EXHIBITS |
|
Saturday, March 22, 2025 |
|
|
|
7:30-8:00 am |
|
REGISTRATION/BREAKFAST |
|
8:00-9:00 am |
1 |
STI Management in the Emergency Department Objectives: 1. Provide an overview of knowledge gaps in STI management within the ED setting 2. Review comprehensive sexual history taking methods and how to identify patients at risk for STIs in the ED 3. Provide an update on novel point-of-care diagnostics for STIs that can be implemented in ED settings 4. Review current recommendations on management of STIs, including expedited partner therapy 5. Discuss the best methods to promote awareness of community and public health STI testing sites for patient follow-up |
Christina Muzny, MD, MSPH, FACP, FIDSA Professor of Medicine, Epidemiology, and Obstetrics/Gynecology University of Alabama at Birmingham |
9:00-10:30 am |
|
Break and Exhibits |
|
10:30-11:30am |
1 |
Poisonous Pit Stops: Exploring the Toxicology of Gas Station Products Objectives: 1. Review current poison center trends in reported exposures to substances found in common gas station products 2. Discuss the underlying pathophysiologic mechanisms that lead to clinical effects for substances found in common gas station products 3. Develop the ability to assess and care for patients with toxicological concerns related to gas station products with potential for toxicity |
Andrew Yetka, PharmD PGY2 Clinical Toxicology Fellow Georgia Poison Center |
11:30-1:30pm |
|
Lunch and Posters |
|
1:30-2:30pm |
1 |
SMART Moves for Asthma Management: Navigating Care in Outpatient and Inpatient Settings Objectives: 1. Define SMART therapy for the management of asthma 2. Recognize asthma exacerbations and the care setting required for treatment 3. Design a therapeutic treatment regimen for a patient in asthma exacerbation, including patients refractory to first line therapies |
Rebecca H. Stone, PharmD, BCPS, BCACP, FCCP Clinical Associate Professor UGA College of Pharmacy Susan E. Smith, PharmD, BCCCP, BCPS Associate Professor University of Georgia College of Pharmacy |
2:30-3:30pm |
1 |
Done in Vein or Done in Vain? Navigating the Benefits and Risks of Peripheral Vasopressor Administration Objectives: 1. Recognize the impact of vasopressor extravasation in critically ill patients 2. Describe instances where peripheral administration may be preferred over central administration 3. Summarize major trial results concerning peripheral vasopressor administration 4. Apply the literature surrounding peripheral vasopressor administration to patient cases and determine guidance for safe implementation of peripheral vasopressors |
Alex Durant, PharmD PGY1 Pharmacy Practice Resident Wellstar MCG Health |
3:30-4:30pm |
1 |
Resident Clinical Pearls: Spring 2024 1. Discuss contemporary issues in pharmacy practice that have been researched and presented by pharmacy residents, fellows, and graduate students. 2. Compare and contrast completed research, research in progress, and special projects conducted to investigate solutions and improvements to contemporary issues in pharmacy practice. 3. Exchange professional information and ideas with colleagues. 4. Discuss issues confronting institutional and community-based practice. 5. Develop and nurture inter-professional relationships. 6. Apply leadership skills among current and future pharmacy practitioners. 7. Participate in an atmosphere that encourages professional network support among conference participants |
Presenters: Aubrey Baker Dion Blocker Morgan Keller Gabrielle McCammack |
4:30-5:30pm |
1 |
ACPE Pharmacy Education Standards: Fundamentals for Lifelong Learning Objectives: 1. Define the Accreditation Council for Pharmacy Education's (ACPE) standards for Continuing Education (CE) 2. Assess gap analyses for alignment with educational session goals and learning activities. 3. Practice selecting the most appropriate learning activity types based on objectives and educational content. |
Meredith Lopez, PharmD, MPH, BCACP Director of Ambulatory Pharmacy & Medication Management Piedmont Healthcare Moderator: Brittany Wheeler, PharmD, MPH, BCACP, BCCP |
Evening |
|
On Your Own-Explore Savannah |
|
Sunday, March 23, 2025 |
|
|
|
7:30-8:00 am |
|
REGISTRATION/BREAKFAST |
|
8:00-9:00am |
1 |
Emergency Management for Pediatric Patients Objectives: 1. Identify critical pediatric emergency medications and dosing considerations 2. Describe practical strategies for managing pediatric patients in adult or rural ED settings 3. Discuss pediatric dosing logistics and administration methods, including pumps, intranasal delivery, and small dose feasibility |
Leigha Davis, PharmD Pediatric Clinical Pharmacist Childrens at Erlanger Hospital |
9:00-10:00am |
1 |
Bringing the Periphery into Focus: Guideline Updates to Peripheral Artery Disease Management Objectives: 1. Describe the epidemiology, disease progression and risk factors and amplifiers of peripheral artery disease 2. Evaluate recent evidence informing guideline updates related to pharmacotherapy management of peripheral artery disease 3. Apply evidence to case examples that highlight patient-specific considerations for medication therapy decisions 4. Discuss growing evidence for health disparities for diagnosis and treatment of peripheral artery disease and how multidisciplinary teams can address these challenges |
Stuart Mackenzie Pope, PharmD, MSPS, BCCCP Cardiac Critical Care Pharmacy Specialist Emory Healthcare |
10:00-11:00am |
1 |
From Readiness to Reality: Embracing Biosimilars Objectives: 1.Describe the FDA approval process for biosimilars 2. Identify adalimumab and other common biosimilar products 3. Construct an opinion on biosimilar hot topics including immunogenicity, switching between biosimilars, and cost 4. Design a plan for biosimilar adoption within a health system |
Lanh T. Dang, PharmD, BCACP Ambulatory Pharmacy Supervisor UF Health Jacksonville |
Registration Cancellation Policy Your meeting registration is fully refundable until February 17, 2025. From February 18-March 3, there is a $25 administrative fee for cancellations. After March 3, there is no refund for cancellations. |